IntroductionThere has been significant speculation regarding the association between Severe Acute RespiratorySyndrome Coronavirus 2 (SARS-CoV-2) pathogen, coronavirus disease (COVID-19) and smoking.We provide an overview of the available literature regarding the association between smoking, risk ofSARS-CoV-2 infection, and risk of severe COVID-19 and poor clinical outcomes, with the aim ofinforming public health policy and practice in England.MethodsPublications were identified utilising a systematic search approach on PUBMED and Google Scholar.Publications presenting a systematic review or meta-analysis considering the association betweensmoking and SARS-COV-2 infection or COVID-19 outcomes were included.ResultsEight studies were identified. One considered the relationship between smoking and the probability ofSARS-CoV-2 infection, three considered the association between COVID-19 hospitalisation andsmoking history and six reviewed the association between smoking history and development ofsevere COVID-19. One study specifically investigated the risk of mortality. The studies consideringrisk of severe disease indicate that there is a significant association between COVID-19 and currentor ever smoking.ConclusionsThis is a rapidly evolving topic. Current analysis remains limited due to the quality of primary data,although early results indicate an association between smoking and COVID-19 severity. We highlyrecommend public health messaging to continue focusing on smoking cessation efforts.